EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intercellular interaction between FAP+ fibroblasts and CD150+ inflammatory monocytes mediates fibrostenosis in Crohn’s disease

Bo-Jun Ke, Saeed Abdurahiman, Francesca Biscu, Gaia Zanella, Gabriele Dragoni, Sneha Santhosh, Veronica De Simone, Anissa Zouzaf, Lies van Baarle, Michelle Stakenborg, Veronika Bosáková, Yentl Van Rymenant und 16 weitere

Journal of Clinical Investigation · 15.08.2024 · 134 (16)

DOI: 10.1172/jci173835 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 23.07.2024. Verfasst von Bo-Jun Ke und 27 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Crohn Disease, Fibroblasts, Twist-Related Protein 1, Monocytes. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KU Leuven Internal Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Crohn’s disease (CD) is marked by recurring intestinal inflammation and tissue injury, often resulting in fibrostenosis and bowel obstruction, necessitating surgical intervention with high recurrence rates. To elucidate the mechanisms underlying fibrostenosis in CD, we analyzed the transcriptome of cells isolated from the transmural ileum of patients with CD, including a trio of lesions from each patient: non-affected, inflamed, and stenotic ileum samples, and compared them with samples from patients without CD. Our computational analysis revealed that profibrotic signals from a subset of monocyte-derived cells expressing CD150 induced a disease-specific fibroblast population, resulting in chronic inflammation and tissue fibrosis. The transcription factor TWIST1 was identified as a key modulator of fibroblast activation and extracellular matrix (ECM) deposition. Genetic and pharmacological inhibition of TWIST1 prevents fibroblast activation, reducing ECM production and collagen deposition. Our findings suggest that the myeloid-stromal axis may offer a promising therapeutic target to prevent fibrostenosis in CD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseFibroblastsTwist-Related Protein 1MonocytesFibrosisHumansMaleNuclear ProteinsFemaleExtracellular MatrixReceptors, Cell SurfaceIleumCell CommunicationAdultEndopeptidasesAnimalsMice

Stichwörter der Autor:innen

FibrosisGastroenterologyInflammationInflammatory bowel diseaseMonocytes

Substanzen

Twist-Related Protein 1TWIST1 protein, humanNuclear ProteinsReceptors, Cell SurfaceEndopeptidases

Autor:innen und Institutionen

  • Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
  • Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom.
  • Gastroenterology Research Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
  • Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
  • Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.

Förderung

  • KU Leuven Internal Funds

Zitieren

APA

Ke, B. J., Abdurahiman, S., Biscu, F., Zanella, G., Dragoni, G., Santhosh, S., De Simone, V., Zouzaf, A., van Baarle, L., Stakenborg, M., Bosáková, V., Van Rymenant, Y., Verhulst, E., Verstockt, S., Klein, E., Bislenghi, G., Wolthuis, A., Frič, J., Breynaert, C., …, & Matteoli, G. (2024). Intercellular interaction between FAP+ fibroblasts and CD150+ inflammatory monocytes mediates fibrostenosis in Crohn’s disease. Journal of Clinical Investigation, 134(16). https://doi.org/10.1172/jci173835

Vancouver

Ke BJ, Abdurahiman S, Biscu F, Zanella G, Dragoni G, Santhosh S, et al. Intercellular interaction between FAP+ fibroblasts and CD150+ inflammatory monocytes mediates fibrostenosis in Crohn’s disease. Journal of Clinical Investigation. 2024;134(16). doi:10.1172/jci173835

BibTeX
@article{Ke2024,
  author = {Ke, Bo-Jun and Abdurahiman, Saeed and Biscu, Francesca and Zanella, Gaia and Dragoni, Gabriele and Santhosh, Sneha and De Simone, Veronica and Zouzaf, Anissa and van Baarle, Lies and Stakenborg, Michelle and Bosáková, Veronika and Van Rymenant, Yentl and Verhulst, Emile and Verstockt, Sare and Klein, Elliott and Bislenghi, Gabriele and Wolthuis, Albert and Frič, Jan and Breynaert, Christine and D'Hoore, Andre and Van der Veken, Pieter and De Meester, Ingrid and Lovisa, Sara and Hawinkels, Lukas Jac and Verstockt, Bram and De Hertogh, Gert and Vermeire, Séverine and Matteoli, Gianluca},
  title = {Intercellular interaction between FAP+ fibroblasts and CD150+ inflammatory monocytes mediates fibrostenosis in Crohn’s disease},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {16},
  doi = {10.1172/jci173835}
}
Kostenlos starten →